2 reports

Overview “Esbriet (pirfenidone) - Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Esbriet (pirfenidone) in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the...

  • Clinical Trial
  • Oral Administration
  • Europe
  • World
  • Japan
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Kemin Industries Italy Oral Administration

  • Pharmaceutical
  • Oral Administration
  • Italy
  • Poultry Production
  • Dates Price